Evaluation the effects of Oxycodone administration on pain control in patients with COVID-19

Phase 3

Recruiting

• Conditions: Covid-19.; COVID-19 Disease; U07.1

• Registration Number: IRCT20150107020592N24
• Lead Sponsor: Vice chancellor for research, Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Covid-19 patients
Patients hospitalized in the intensive care unit

Exclusion Criteria

Patients with dissatisfaction with drug use

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain in hospitalized patients based on the pain questionnaire. Timepoint: The first to seventh days after the onset of oxycodone. Method of measurement: Pain scale (VAS).